Form 10-Q · Quarterly report
DuPont 10-Q, filed Nov 3, 2026
- Filed
- CIK
- 0001666700
- Accession no.
- 0001666700-26-000060
Summary
DuPont reported third-quarter 2026 net sales of $1.9 billion, up 4 percent from a year earlier on 5 percent organic growth, and held about $1.7 billion in cash and cash equivalents as of September 30, 2026. The quarter's results followed the April 2026 sale of its Aramids business to Arclin and the November 2025 separation of its electronics business into Qnity Electronics, and reflect a 1-for-3 reverse stock split effective June 24, 2026.
Key points
- Net sales for the three months ended September 30, 2026 were $1.9 billion, up 4 percent from $1.8 billion a year earlier, with organic sales up 5 percent and a 1 percent unfavorable currency impact.
- DuPont completed the sale of its Aramids business to Arclin, a TJC LP portfolio company affiliate, on April 1, 2026 for about $1.2 billion in pre-tax cash, a $300 million note receivable and a $325 million non-controlling equity interest.
- DuPont completed the separation of its semiconductor and interconnect solutions businesses into Qnity Electronics, Inc. on November 1, 2025, and the results of that business are reported as discontinued operations.
- The Board declared a fourth quarter 2026 dividend of $0.60 per share, payable December 15, 2026 to shareholders of record on November 30, 2026.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
From the filing
ITEM 2. MANAGEMENT'S DISCUSSION OVERVIEW DuPont is a leading provider of advanced solutions that improve everyday life across healthcare, water, construction and industrial markets. The Company is committed to helping customers advance their technology pipelines and provide solutions that address their unique challenges. From delivering clean water to enabling medical packaging solutions which enhance safety and performance, DuPont's innovations power the essential products and technologies people rely on every day. As of September 30, 2026, the Company had $2.7 billion of working capital and approximately $1.7 billion in cash and cash equivalents. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.